VALLERINI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 5.682
EU - Europa 2.348
AS - Asia 826
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 8
AF - Africa 2
Totale 8.878
Nazione #
US - Stati Uniti d'America 5.662
GB - Regno Unito 854
SE - Svezia 422
IT - Italia 359
CN - Cina 286
SG - Singapore 212
DE - Germania 194
HK - Hong Kong 133
UA - Ucraina 117
FI - Finlandia 107
TR - Turchia 91
FR - Francia 72
BG - Bulgaria 48
RU - Federazione Russa 46
IN - India 42
BE - Belgio 29
CZ - Repubblica Ceca 28
ID - Indonesia 21
IE - Irlanda 13
CA - Canada 12
VN - Vietnam 12
LT - Lituania 10
EU - Europa 9
MY - Malesia 9
BZ - Belize 8
NL - Olanda 8
IR - Iran 7
ES - Italia 6
PL - Polonia 6
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AT - Austria 4
DK - Danimarca 3
GR - Grecia 3
JP - Giappone 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
KR - Corea 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BR - Brasile 1
EC - Ecuador 1
EE - Estonia 1
GN - Guinea 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
PE - Perù 1
SY - Repubblica araba siriana 1
Totale 8.878
Città #
Fairfield 801
Southend 686
Santa Clara 532
Woodbridge 486
Ashburn 464
Chandler 432
Houston 359
Ann Arbor 344
Seattle 283
Nyköping 249
Wilmington 233
Cambridge 224
Jacksonville 216
Dearborn 211
Singapore 140
Hong Kong 130
Modena 115
New York 85
Helsinki 66
Beijing 64
Fremont 63
San Diego 53
Sofia 47
Princeton 46
Bremen 45
Eugene 44
Izmir 43
Des Moines 32
Brussels 27
Boardman 26
London 24
Redwood City 22
Jakarta 21
Munich 21
Milan 20
Moscow 19
Shanghai 16
San Jose 14
Bologna 13
Dallas 12
Dublin 12
Las Vegas 12
Hefei 11
Kunming 11
Dong Ket 10
Toronto 10
Albuquerque 9
Brno 9
Chicago 9
Belize City 8
Kilburn 8
Washington 8
Guangzhou 7
Paris 7
Bangalore 6
Chiswick 6
Leawood 6
Nanjing 6
Norwalk 6
Rome 6
San Francisco 6
Bengaluru 5
Istanbul 5
Jinan 5
Prescot 5
Tulare 5
Wuhan 5
Dongguan 4
Kosice 4
Perugia 4
Rimini 4
Romainville 4
San Giuliano Milanese 4
Verona 4
Asti 3
Changsha 3
Chengdu 3
Columbus 3
Florence 3
Grafing 3
Hanover 3
Hounslow 3
Marienheide 3
Nanchang 3
Sacramento 3
Saint Louis 3
San Mateo 3
Segrate 3
Simi Valley 3
Sissa 3
Stockholm 3
Szczecin 3
Taipei 3
Vienna 3
Amsterdam 2
Andover 2
Atlanta 2
Boca 2
Boretto 2
Cachan 2
Totale 7.031
Nome #
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 296
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 283
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 258
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 257
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 251
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 244
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 238
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 237
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 231
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 226
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 219
Mucorales-specific T cells in patients with hematologic malignancies 218
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 214
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 213
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 213
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 212
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 212
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 212
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 211
B cells and herpesviruses: a model of lymphoproliferation 209
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 207
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 205
Diagnosis of aspergillosis: Role of proteomics 203
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 200
Parvoviruses in blood donors and transplant patients, Italy 194
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 194
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 194
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 187
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 187
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 184
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 184
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 181
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 174
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 173
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 166
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 166
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 161
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 157
KSHV/HHV-8 infection of tubular epithelial cells in transplantation kidney 153
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 152
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 151
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 149
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 146
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 139
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 135
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 27
Totale 9.023
Categoria #
all - tutte 33.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.261 0 0 0 0 0 256 368 245 175 60 80 77
2020/20211.396 99 77 90 180 177 94 78 177 65 184 94 81
2021/20221.124 44 138 143 61 27 41 61 57 96 99 225 132
2022/20231.284 191 180 80 129 197 151 47 108 100 9 51 41
2023/2024778 19 26 63 60 156 100 79 139 14 10 53 59
2024/2025979 84 32 51 154 363 295 0 0 0 0 0 0
Totale 9.023